Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 26

Trial Status

Completed6
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT05216120Phase 2Withdrawn
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Pancreas Cancer
PrincipalinvestigatorStart date: 2022-06-14
NCT05229588Phase 2Completed
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
Gastrointestinal Malignancies
PrincipalinvestigatorStart date: 2022-06-14
NCT04669197Phase 2Completed
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaUntreated Resectable Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2020-12-01
NCT03415854Phase 2Completed
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
AdenocarcinomaPancreas MetastasesPancreatic Adenocarcinoma+2 more
PrincipalinvestigatorStart date: 2018-01-31
NCT03138720Phase 2Completed
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
Neoadjuvant Pancreatic CancerPancreatic AdenocarcinomaResectable Pancreatic Cancer+1 more
PrincipalinvestigatorStart date: 2017-05-23
NCT02790944Completed
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
PrincipalinvestigatorStart date: 2016-05-04
NCT02754726Phase 2Completed
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
PrincipalinvestigatorStart date: 2016-04-01

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nadine Tung, MD

Beth Israel Deaconess

Related
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma

Worked with same sponsors:

Ambry GeneticsBeth Israel Deaconess Medical Center+2 more
Collaborated on 1 trial
Similarity Score14%

Randall Brand, MD

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

Pancreatic Ductal Adenocarcinoma

Worked with same sponsors:

Ambry GeneticsBeth Israel Deaconess Medical Center+2 more
Collaborated on 1 trial
Similarity Score14%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Cancer of PancreasPancreatic Ductal AdenocarcinomaResectable Pancreatic Cancer
Similarity Score7%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Pancreatic Ductal AdenocarcinomaPancreatic AdenocarcinomaCancer of Pancreas
Similarity Score7%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of PancreasAdenocarcinoma
Similarity Score5%

Lillian Siu, MD

Princess Margaret Cancer Centre

Related
12 trials

Shared therapeutic areas:

Pancreatic AdenocarcinomaPancreatic Ductal Adenocarcinoma
Similarity Score5%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score2%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score2%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score2%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Cancer of Pancreas
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT05216120Phase 2PrincipalInvestigator

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Pancreas Cancer
Withdrawn
NCT05229588Phase 2PrincipalInvestigator

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

Gastrointestinal Malignancies
Completed
NCT04669197Phase 2PrincipalInvestigator

Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer

Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaUntreated Resectable Pancreatic Adenocarcinoma
Completed
NCT03415854Phase 2PrincipalInvestigator

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

AdenocarcinomaPancreas MetastasesPancreatic Adenocarcinoma+2 more
Completed
NCT03138720Phase 2PrincipalInvestigator

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Neoadjuvant Pancreatic CancerPancreatic AdenocarcinomaResectable Pancreatic Cancer+1 more
Completed
NCT02790944PrincipalInvestigator

Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma
Completed
NCT02754726Phase 2PrincipalInvestigator

Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Completed

All 7 trials loaded